Wealth First Portfolio Managers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 7:24 pm

Quick Insight

Wealth First Portfolio Managers Ltd's financial metrics paint a compelling picture for investors. With an intrinsic value of ₹1,234 and a market capitalization of ₹1,315 Cr., the stock seems slightly undervalued. A high P/E ratio of 35.3 indicates strong growth potential, complemented by impressive returns on equity (ROE) at 28.5% and returns on capital employed (ROCE) at 37.5%. The company's robust operating profit margin (OPM) of 88% showcases efficient cost management, leading to a healthy net profit of ₹34 Cr. Furthermore, a comfortable current ratio of 500.36x and a low debt level with zero borrowings demonstrate sound financial health. Overall, Wealth First Portfolio Managers Ltd appears to be a solid investment opportunity in the finance and investments sector.

Competitors of Wealth First Portfolio Managers Ltd

All Competitor Stocks of Wealth First Portfolio Managers Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:15 am

Below is a detailed analysis of the quarterly data for Wealth First Portfolio Managers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 29.00 Cr..
• For Expenses, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from -6.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 28.00 Cr..
• For OPM %, as of Jun 2025, the value is 88.00%. The value appears strong and on an upward trend. It has increased from 0.00% (Mar 2025) to 88.00%, marking an increase of 88.00%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from -6.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 28.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from -24.00% (Mar 2025) to 26.00%, marking an increase of 50.00%.
• For Net Profit, as of Jun 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 20.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 15.23. The value appears strong and on an upward trend. It has increased from -4.01 (Mar 2025) to 15.23, marking an increase of 19.24.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:47 am

Balance Sheet

Last Updated: July 25, 2025, 2:04 pm

Below is a detailed analysis of the balance sheet data for Wealth First Portfolio Managers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 107.00 Cr. (Mar 2024) to 117.00 Cr., marking an increase of 10.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 135.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 125.00 Cr. (Mar 2024) to 135.00 Cr., marking an increase of 10.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Mar 2024) to 31.00 Cr., marking a decrease of 18.00 Cr..
• For Other Assets, as of Mar 2025, the value is 103.00 Cr.. The value appears strong and on an upward trend. It has increased from 75.00 Cr. (Mar 2024) to 103.00 Cr., marking an increase of 28.00 Cr..
• For Total Assets, as of Mar 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 125.00 Cr. (Mar 2024) to 135.00 Cr., marking an increase of 10.00 Cr..

Notably, the Reserves (117.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Wealth First Portfolio Managers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 32.05. This value is within the healthy range. It has decreased from 40.06 (Mar 24) to 32.05, marking a decrease of 8.01.
• For Diluted EPS (Rs.), as of Mar 25, the value is 32.05. This value is within the healthy range. It has decreased from 40.06 (Mar 24) to 32.05, marking a decrease of 8.01.
• For Cash EPS (Rs.), as of Mar 25, the value is 32.38. This value is within the healthy range. It has decreased from 40.40 (Mar 24) to 32.38, marking a decrease of 8.02.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 120.61. It has increased from 111.00 (Mar 24) to 120.61, marking an increase of 9.61.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 120.61. It has increased from 111.00 (Mar 24) to 120.61, marking an increase of 9.61.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 49.89. It has decreased from 50.99 (Mar 24) to 49.89, marking a decrease of 1.10.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 44.19. This value is within the healthy range. It has decreased from 52.40 (Mar 24) to 44.19, marking a decrease of 8.21.
• For PBIT / Share (Rs.), as of Mar 25, the value is 43.85. This value is within the healthy range. It has decreased from 52.05 (Mar 24) to 43.85, marking a decrease of 8.20.
• For PBT / Share (Rs.), as of Mar 25, the value is 42.35. This value is within the healthy range. It has decreased from 52.01 (Mar 24) to 42.35, marking a decrease of 9.66.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 32.05. This value is within the healthy range. It has decreased from 40.06 (Mar 24) to 32.05, marking a decrease of 8.01.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 32.05. This value is within the healthy range. It has decreased from 40.06 (Mar 24) to 32.05, marking a decrease of 8.01.
• For PBDIT Margin (%), as of Mar 25, the value is 88.57. This value is within the healthy range. It has decreased from 102.75 (Mar 24) to 88.57, marking a decrease of 14.18.
• For PBIT Margin (%), as of Mar 25, the value is 87.89. This value exceeds the healthy maximum of 20. It has decreased from 102.08 (Mar 24) to 87.89, marking a decrease of 14.19.
• For PBT Margin (%), as of Mar 25, the value is 84.88. This value is within the healthy range. It has decreased from 101.99 (Mar 24) to 84.88, marking a decrease of 17.11.
• For Net Profit Margin (%), as of Mar 25, the value is 64.23. This value exceeds the healthy maximum of 10. It has decreased from 78.55 (Mar 24) to 64.23, marking a decrease of 14.32.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 64.23. This value exceeds the healthy maximum of 20. It has decreased from 78.55 (Mar 24) to 64.23, marking a decrease of 14.32.
• For Return on Networth / Equity (%), as of Mar 25, the value is 26.56. This value is within the healthy range. It has decreased from 36.08 (Mar 24) to 26.56, marking a decrease of 9.52.
• For Return on Capital Employeed (%), as of Mar 25, the value is 36.16. This value is within the healthy range. It has decreased from 46.62 (Mar 24) to 36.16, marking a decrease of 10.46.
• For Return On Assets (%), as of Mar 25, the value is 25.07. This value is within the healthy range. It has decreased from 34.18 (Mar 24) to 25.07, marking a decrease of 9.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has decreased from 0.52 (Mar 24) to 0.40, marking a decrease of 0.12.
• For Current Ratio (X), as of Mar 25, the value is 12.53. This value exceeds the healthy maximum of 3. It has increased from 11.50 (Mar 24) to 12.53, marking an increase of 1.03.
• For Quick Ratio (X), as of Mar 25, the value is 2.34. This value exceeds the healthy maximum of 2. It has increased from 1.85 (Mar 24) to 2.34, marking an increase of 0.49.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.48 (Mar 24) to 0.00, marking a decrease of 7.48.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.42 (Mar 24) to 0.00, marking a decrease of 7.42.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.52 (Mar 24) to 0.00, marking a decrease of 92.52.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.58 (Mar 24) to 0.00, marking a decrease of 92.58.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 500.36. This value is within the healthy range. It has decreased from 1,160.18 (Mar 24) to 500.36, marking a decrease of 659.82.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 379.86. This value is within the healthy range. It has decreased from 887.91 (Mar 24) to 379.86, marking a decrease of 508.05.
• For Enterprise Value (Cr.), as of Mar 25, the value is 939.67. It has increased from 661.72 (Mar 24) to 939.67, marking an increase of 277.95.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 17.68. This value exceeds the healthy maximum of 3. It has increased from 12.18 (Mar 24) to 17.68, marking an increase of 5.50.
• For EV / EBITDA (X), as of Mar 25, the value is 19.96. This value exceeds the healthy maximum of 15. It has increased from 11.85 (Mar 24) to 19.96, marking an increase of 8.11.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 17.73. This value exceeds the healthy maximum of 3. It has increased from 12.27 (Mar 24) to 17.73, marking an increase of 5.46.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 92.51 (Mar 24) to 0.00, marking a decrease of 92.51.
• For Price / BV (X), as of Mar 25, the value is 7.33. This value exceeds the healthy maximum of 3. It has increased from 5.64 (Mar 24) to 7.33, marking an increase of 1.69.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 17.73. This value exceeds the healthy maximum of 3. It has increased from 12.27 (Mar 24) to 17.73, marking an increase of 5.46.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness